Physician profile
Mary E Ciesa
NPI 1417971359
$1,263.85
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,022 · 2022: $241.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.72 | 2021-2022 | |
| Novo Nordisk INC | $143.41 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.11 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $100.21 | 2021 | |
| Lilly USA, LLC | $88.39 | 2021 | |
| Alfasigma USA, INC. | $79.70 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $69.76 | 2021 | |
| Pfizer INC. | $48.57 | 2021-2022 | |
| Astellas Pharma US INC | $43.73 | 2021 | |
| Amarin Pharma, INC. | $40.98 | 2021 | |
| Amgen INC. | $40.96 | 2021-2022 | |
| Biogen, INC. | $37.22 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.84 | 2021 | |
| Biocryst US Sales Co., LLC | $35.74 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.22 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $28.42 | 2021 | |
| Glaxosmithkline, LLC. | $27.38 | 2021 | |
| Radius Health, INC. | $19.27 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.85 | 2021 | |
| Baxter Healthcare | $15.88 | 2022 | |
| Seqirus USA INC | $14.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.62 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.17 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ciesa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.